CompletedNot Applicable

Smartphone Intervention for Overdose and COVID-19

United States60 participantsStarted 2022-12-19

Plain-language summary

This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years old or older * Willing to attend in person study encounters at any of the following Vivent Health locations: Milwaukee, Appleton, and Eau Claire * Used opioids to get high in the past 30 days * Injected drugs at least 2 times in the past 7 days * Express interest in reducing their overdose risk Exclusion Criteria: * None in addition to the inclusion criteria

What they're measuring

Content Completion Rate Assessed as Number of Participants Who Completed at Least 6 of the 12 Weeks of the Intervention

Timeframe: up to 12 weeks

Trial details

NCT IDNCT05518461

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-15

Results submitted2024-11-13

View on ClinicalTrials.gov More Substance Use Disorders trials